No Data
No Data
Stock market anomaly: hainan shuangcheng pharmaceuticals may be given the special treat symbol, consecutive two-day limit down.
Gelonghui November 12th | "Monster stock" Hainan Shuangcheng Pharmaceuticals (002693.SZ) has been continuously limit-down for 2 days in a row, closing at 24.93 yuan, with a total market value of 10.34 billion yuan. Hainan Shuangcheng Pharmaceuticals, which sparked speculative buying with mergers and acquisitions restructuring, faces the risk of being warned of the risk of delisting (*Special Treat). Recently, Hainan Shuangcheng Pharmaceuticals released an announcement on the progress and risk warnings of a major asset restructuring. The company indicated that in the first three quarters of 2024, the company's revenue was 0.127 billion yuan, and the net income was negative. If in 2024 the company's performance triggers financial delisting indicators with negative net income and revenue below 0.3 billion yuan, *Special Treat will be implemented.
High-level stocks continue to decline, with many stocks such as China Zhonghua Geotechnical Engineering Group continuously hitting the limit down.
Gelonghui November 12th | China Zhonghua Geotechnical Engineering Group, Hainan Shuangcheng Pharmaceuticals, Nanfang Black Sesame Group, Landai Technology Group Corp., China Fortune Land Development, CPT Technology have consecutively hit the limit down for two days, Xiwang Foodstuffs, Ribo Fashion Group and others are among the top decliners.
Express News | Hainan Shuangcheng Pharmaceuticals: As of the announcement disclosure date, the company and relevant parties are actively advancing various work of this trade.
Express News | hainan shuangcheng pharmaceuticals: There have been no significant changes in the recent operation of the company and the internal and external operating environment.
High-priced A-shares continue to plunge.
November 4th, Gelonhui: Hytera Communications Corporation, Hainan Shuangcheng Pharmaceuticals, Dongguan Huali Industries, Datang Telecom Technology and other stocks experienced a limit-down in bidding.
High-priced stocks continue to decline, with more than 20 popular stocks like hainan shuangcheng pharmaceuticals hitting the limit down.
On November 1st, Hainan Shuangcheng Pharmaceuticals, Shanghai CDXJ Digital Technology, Weihai Huadong Automation, Datang Telecom Technology, Chongqing Zonsen Power Machinery, Cashway Fintech, Hefei Taihe Intelligent Technology Group, Zhejiang Yueling, and more than 20 market popular stocks have hit the limit down.
No Data
No Data